♦Bicalutamide

Jul 20, 2016 by in ONCOLOGY Comments Off on ♦Bicalutamide

♦Bicalutamide (bye-ka-loo’-ta-myde) Casodex Pregnancy Category X Mechanism of Action Bicalutamide is a nonsteroidal antiandrogen that inhibits the uptake and binding of androgens to the androgen receptors in the prostate gland…

read more

♦Anastrozole

Jul 20, 2016 by in ONCOLOGY Comments Off on ♦Anastrozole

♦Anastrozole (an-as’-troo-zol) Arimidex Pregnancy Category C Mechanism of Action Anastrozole is a selective nonsteroidal aromatase inhibitor. Many breast cancers have estrogen receptors; the growth of these tumors is stimulated by…

read more

♦Aminoglutethimide

Jul 20, 2016 by in ONCOLOGY Comments Off on ♦Aminoglutethimide

♦Aminoglutethimide (a-meen-oh-glow-teth’-i-mide) Cytadren Pregnancy Category D Mechanism of Action Inhibits adrenocortical steroid synthesis by blocking the production of adrenal glucocorticoids, mineralocorticoids, estrogens, and androgens. Indications Suppression of adrenal function in…

read more

♦Amifostine

Jul 20, 2016 by in ONCOLOGY Comments Off on ♦Amifostine

♦Amifostine (a-mee-phos’-tin) Ethyol Pregnancy Category C Mechanism of Action Amifostine is dephosphorylated at the tissue site by alkaline phosphatase to form free thiol. Once inside the cell, the free thiol…

read more

♦Altretamine

Jul 20, 2016 by in ONCOLOGY Comments Off on ♦Altretamine

♦Altretamine (al-treh’-tah-meen) Hexalen Pregnancy Category D Mechanism of Action Unknown Indications ♦ Palliative treatment for recurrent or persistent ovarian cancer after first-line therapy with cisplatin or alkylating agent; use as…

read more

♦Aldesleukin

Jul 20, 2016 by in ONCOLOGY Comments Off on ♦Aldesleukin

♦Aldesleukin (al-des-loo’-ken) Proleukin, interleukin-2 Pregnancy Category C Mechanism of Action Inhibits tumor growth; exerts immunologic effects by activating the cellular immunity to increase lymphocytes, eosinophils, platelets, and cytokines, including tumor…

read more

FDA Pregnancy Categories

Jul 20, 2016 by in ONCOLOGY Comments Off on FDA Pregnancy Categories

FDA Pregnancy Categories The Food and Drug Administration has established five categories to indicate the potential for a systemically absorbed drug to cause birth defects. The key differentiation among the…

read more

Patient Education

Jul 20, 2016 by in ONCOLOGY Comments Off on Patient Education

Patient Education Patient education is an important component of care. An increasing number of cancer patients are undergoing multiple treatment modalities, and they need knowledge and skills to cope with…

read more

Management of Toxic Effects of Chemotherapy

Jul 20, 2016 by in ONCOLOGY Comments Off on Management of Toxic Effects of Chemotherapy

Management of Toxic Effects of Chemotherapy Chemotherapy, like any medication, has the potential to cause side effects. Unique to these agents, however, are the nature and extent of the injury…

read more

Management of Hypersensitivity Reactions and Extravasation

Jul 20, 2016 by in ONCOLOGY Comments Off on Management of Hypersensitivity Reactions and Extravasation

Management of Hypersensitivity Reactions and Extravasation Hypersensitivity Reactions Hypersensitivity reactions (HSRs) are common in patients receiving chemotherapy. These reactions, which may be local or systemic, are believed to be immunologically…

read more
Get Clinical Tree app for offline access